Loading patent…
AssigneesThe Trustees of Columbia University in the City of New York, SmithKline Beckman Corporation
InventorsPaul J. Maddon, Richard Axel, Raymond W. Sweet, James Arthos
Estimating the term…
This invention provides a therapeutic agent capable of specifically forming a complex with human immunodeficiency virus envelope glycoprotein which comprises a polypeptide. In one embodiment of the invention, the amino acid sequence of the polypeptide has the amino acid sequence shown in FIG. 6 from about +1 to about +185 fused to the amino acid sequence from about +353 to about +371. In another embodiment of the invention, the amino acid sequence of the polypeptide has the amino acid sequence shown in FIG. 6 from about +1 to about +106 fused to the amino acid sequence from about +353 to about +371. In yet a further embodiment of the invention, the amino acid sequence of the polypeptide has the amino acid sequence shown in FIG. 6 from about +1 to about +185. This invention also provides a method for treating a subject infected with a human immunodeficiency virus. The method treats the subject with an effective amount of a pharmaceutical composition having an effective amount of a therapeutic agent of the invention and a pharmaceutically acceptable carrier.
An expression vector encoding a peptide consisting of the amino acid sequence;
An expression vector encoding a peptide consisting of the amino acid sequence:
An expression vector encoding a peptide consisting of the amino acid sequence;
Dependencies are inferred from the claim text.